Stefan Kaltenbacher takes over as Head of Healthcare from Bryan, Garnier & Co.

4. May 2020

Paris/Munich — Stefan Kalten­ba­cher (56), photo, will head Bryan, Garnier and Co. ’s German-spea­­king invest­ment banking acti­vi­ties in the life scien­ces sector (DACH region) from May 1, 2020. The new Mana­ging Direc­tor has exten­sive gene­ral manage­ment expe­ri­ence in the phar­maceu­ti­cal and medi­cal tech­no­logy indus­try as well as in private equity: Among other things, he was respon­si­ble for the Nort­hern and Central Euro­pean busi­ness of the medi­cal tech­no­logy company Care­Fu­sion (now part of Becton Dick­in­son), led the medi­cal device sector of John­son & John­son in Germany and Austria, and was a member of John­son & Johnson’s Stra­tegy Team Europe. Prior to that, he worked in Paris and London as direc­tor for the inter­na­tio­nal diagnostics divi­sion of Bayer AG. Most recently, as Mana­ging Direc­tor of an owner-mana­­ged, inde­pen­dent M&A consul­tancy, he advi­sed a large number of growth compa­nies and estab­lis­hed compa­nies in the German-spea­­king region and was Senior Advi­sor to Deut­sche Betei­li­gungs­ge­sell­schaft, Frank­furt, on its enga­ge­ments in the life scien­ces sector.

“Parti­cu­larly in the life scien­ces sector, indus­try expe­ri­ence is abso­lutely essen­tial and we are deligh­ted to have gained such an expe­ri­en­ced indus­try expert for our German team,” empha­si­zes Falk Müller-Veerse, who as Part­ner is respon­si­ble for Bryan, Garnier & Co.’s busi­ness in the DACH region.

The health­care indus­try is a central focus of the invest­ment bank for tech­no­logy compa­nies, which was foun­ded in Paris and London in 1996: Bryan, Garnier & Co. was invol­ved in the success­ful Nasdaq IPO of biotech company Bion­Tech, accom­pa­nied medi­cal tech­no­logy company Medar­tis to the Swiss stock exchange, and orches­tra­ted a number of private finan­cing rounds of life scien­ces start-ups with global inves­tors, among others.

About Bryan, Garnier & Co
Bryan, Garnier & Co, foun­ded in 1996 in Paris and London, is an invest­ment bank focu­sed on Euro­pean growth compa­nies with a presence in London, Paris, Munich, Stock­holm, Oslo, Reykja­vík, New York, Palo Alto and Shang­hai. As an inde­pen­dent full-service invest­ment bank, it offers compre­hen­sive finan­cing advice and support along the entire life cycle of its clients — from initial finan­cing rounds to a poten­tial sale or IPO with subse­quent follow-up finan­cing. The range of services inclu­des equity analy­sis, equity sales and trading, private and public capi­tal raising, and M&A advi­sory for growth compa­nies and their inves­tors. The focus is on the growth sectors of tech­no­logy, health­care, bran­ded and consu­mer goods, and busi­ness services. Bryan Garnier is a regis­tered broker and licen­sed with the FCA in Europe and FINRA in the US.

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at]